CYYR1 promotes the degradation of the E3 ubiquitin ligase WWP1 and is associated with favorable prognosis in breast cancer
Journal of Biological Chemistry · 2024-09 · 300 (9) · 107601
DOI: 10.1016/j.jbc.2024.107601 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Biological Chemistry, 2024-09. Verfasst von Tiphaine Perron und 9 weiteren Autor:innen. Beteiligte Einrichtung: Sorbonne Université, INSERM UMR_S 938, Centre de Recherche Saint-Antoine, CRSA, Paris, France. Hauptthemen laut MEDLINE: Ubiquitin-Protein Ligases, Breast Neoplasms, Ubiquitination, Proteolysis. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ligue Nationale Contre Le Cancer.
Abstract (Originalsprache)
Ubiquitination plays a crucial role in cellular homeostasis by regulating the degradation, localization, and activity of proteins, ensuring proper cell function and balance. Among E3 ubiquitin ligases, WW domain-containing protein 1 (WWP1) is implicated in cell proliferation, survival, and apoptosis. Notably WWP1 is frequently amplified in breast cancer and associated with poor prognosis. Here, we identify the protein cysteine and tyrosine-rich protein 1 (CYYR1) that had previously no assigned function, as a regulator of WWP1 activity and stability. We show that CYYR1 binds to the WW domains of the E3 ubiquitin ligase WWP1 through its PPxY motifs. This interaction triggers K63-linked autoubiquitination and subsequent degradation of WWP1. We furthermore demonstrate that CYYR1 localizes to late endosomal vesicles and directs polyubiquitinated WWP1 toward lysosomal degradation through binding to ANKyrin repeat domain-containing protein 13 A (ANKRD13A). Moreover, we found that CYYR1 expression attenuates breast cancer cell growth in anchorage-dependent and independent colony formation assays in a PPxY-dependent manner. Finally, we highlight that CYYR1 expression is significantly decreased in breast cancer and is associated with beneficial clinical outcome. Taken together our study suggests tumor suppressor properties for CYYR1 through regulation of WWP1 autoubiquitination and lysosomal degradation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Sorbonne Université, INSERM UMR_S 938, Centre de Recherche Saint-Antoine, CRSA, Paris, France.
- Sorbonne Université, INSERM UMR_S 938, Centre de Recherche Saint-Antoine, CRSA, Paris, France; APHP, Hôpitaux Universitaires Pitié-Salpêtrière-Charles Foix, Laboratoire de Biochimie Endocrinienne et Oncologique, Oncobio…
- Department of Genetics, Institut Curie, Université Paris Cité, Paris, France.
- CurieCoreTech Mass Spectrometry Proteomics, Institut Curie, PSL Research University, Paris, France.
- Sorbonne Université, INSERM UMR_S 938, Centre de Recherche Saint-Antoine, CRSA, Paris, France. Electronic address: laurence.levy@inserm.fr.
- Sorbonne Université, INSERM UMR_S 938, Centre de Recherche Saint-Antoine, CRSA, Paris, France. Electronic address: celine.prunier@inserm.fr.
Förderung
- Ligue Nationale Contre Le Cancer
Zitieren
APA
Perron, T., Boissan, M., Bièche, I., Courtois, L., Dingli, F., Loew, D., Chouchène, M., Colasse, S., Levy, L., & Prunier, C. (2024). CYYR1 promotes the degradation of the E3 ubiquitin ligase WWP1 and is associated with favorable prognosis in breast cancer. Journal of Biological Chemistry, 300(9), 107601. https://doi.org/10.1016/j.jbc.2024.107601
Vancouver
Perron T, Boissan M, Bièche I, Courtois L, Dingli F, Loew D, et al. CYYR1 promotes the degradation of the E3 ubiquitin ligase WWP1 and is associated with favorable prognosis in breast cancer. Journal of Biological Chemistry. 2024;300(9):107601. doi:10.1016/j.jbc.2024.107601
BibTeX
@article{Perron2024,
author = {Perron, Tiphaine and Boissan, Mathieu and Bièche, Ivan and Courtois, Laura and Dingli, Florent and Loew, Damarys and Chouchène, Mouna and Colasse, Sabrina and Levy, Laurence and Prunier, Céline},
title = {CYYR1 promotes the degradation of the E3 ubiquitin ligase WWP1 and is associated with favorable prognosis in breast cancer},
journal = {Journal of Biological Chemistry},
year = {2024},
volume = {300},
number = {9},
pages = {107601},
doi = {10.1016/j.jbc.2024.107601}
}
EUVIMED